France
OXELTIS is an independent medchem oriented service company managed by former researchers from Idenix Pharmaceuticals and located in Montpellier - France. OXELTIS delivers integrated solutions for managing and executing medicinal and fine organic chemistry projects. The company runs FTE programs (hit to lead optimization) with expertise in specialty chemistry such as macrocycles, mono & poly/oligosaccharides, nucleos(t)ides, short peptides, linkers, and PROTACs applied to discovery programs in oncology, antivirals, and antibiotics mainly.
OXELTIS' client portfolio includes 40+ European and US companies from biotech to top 10 pharmaceutical companies. With a team of experienced medchem chemists, OXELTIS is proactive in providing rapid, high quality, and competitive work. The company's specific expertise lies in contract research in medicinal chemistry, FTE programs for hit to lead optimization in different fields including antivirals, anticancer, and antibiotics, as well as fee-for-service custom synthesis expertise in various chemistry domains.
Established in 2010, OXELTIS operates within the Life Sciences and Pharmaceutical industries. For more information, visit their website or Twitter account.